Catarina Flyborg

Vice President Cell and Gene Therapy Cytiva Catarina Flyborg is driven by the promise of cell and gene therapies to transform global healthcare, change the way diseases are treated and significantly improve patient outcomes. An accomplished engineer and scientist, Catarina has held various management positions in sales, marketing, communications and product development, giving her a […]

Read More… from Catarina Flyborg

Edward (Ted) Sargent

Vice-President, Research and Innovation, and Strategic Initiatives University of Toronto University Professor Edward (Ted) Sargent received a BScEng (Engineering Physics) from Queen’s University and a PhD in Electrical and Computer Engineering (Photonics) from the University of Toronto. He joined the Edward S. Rogers Sr. Department of Electrical and Computer Engineering at the University of Toronto in […]

Read More… from Edward (Ted) Sargent

Peter Zandstra

Chief Scientific Officer, CCRM University of British Columbia Peter Zandstra graduated with a Bachelor of Engineering degree from McGill University in the Department of Chemical Engineering, obtained his Ph.D. degree from the University of British Columbia (UBC) in the Department of Chemical Engineering and Biotechnology and continued his research training as a Post Doctoral Fellow […]

Read More… from Peter Zandstra

Michael May

President & Chief Executive Officer CCRM Dr. Michael May completed his PhD in Chemical Engineering at the University of Toronto in 1998 as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. He is President and Chief Executive Officer of CCRM. Prior to CCRM, Michael was the President and co-founder of […]

Read More… from Michael May

Reni Benjamin

Managing Director and Senior Biotechnology Analyst JMP Securities Dr. Reni Benjamin is a Managing Director and Senior Biotechnology Analyst at JMP Securities. His coverage consists of small/mid-cap biotechnology companies in the oncology sector. Dr. Benjamin has previously been ranked for recommendation performance and earnings accuracy by StarMine, cited in the Wall Street Journal, Business Week, Financial Times, […]

Read More… from Reni Benjamin

Claudia Zylberberg

Founder & CEO Akron Biotechnology Claudia Zylberberg, Ph.D., is a leader in regenerative medicine. She is the founder and CEO of Akron Biotechnology, a leading developer and manufacturer of cGMP-grade ancillary materials and a purveyor of specialized services to cell and gene therapy developers, contract development and manufacturing organizations, and tissue engineering companies, among others. Under Dr. […]

Read More… from Claudia Zylberberg

Joan Sheehan

Vice President, Sales STEMCELL Technologies   Joan Sheehan joined STEMCELL in 1993 and since then has built and managed a number of different functions across the company including Product and Scientific Support, Education, Customer Service, Distribution, Marketing and Sales. Joan has been instrumental in growing revenue from $1 million to $300 million over the past 26 […]

Read More… from Joan Sheehan

Michael Nobrega

Chair, Board of Directors Ontario Centres of Excellence, Canada Michael Nobrega has been Chair of the Board of Directors of Ontario Centres of Excellence (OCE) since 2012, previously serving as a member since 2007. He is former President and CEO of the Ontario Municipal Employees Retirement System (OMERS), one of Canada’s largest pension plans with […]

Read More… from Michael Nobrega